Palomino Laboratories (PALX) EPS (Basic) (2023 - 2025)

Palomino Laboratories (PALX) has 3 years of EPS (Basic) data on file, last reported at -$0.47 in Q3 2025.

• For the quarter ending Q3 2025, EPS (Basic) fell 212134.47% year-over-year to -$0.47; the trailing twelve-month figure through Dec 2025 stood at -$0.25 (down 395.57% YoY), and the FY2024 full-year result was -$0.03, down 22.73% from the prior year.
• EPS (Basic) declined to -$0.47 in Q3 2025, from -$0.01 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of -$0.0 in Q3 2024 to a low of -$0.47 in Q3 2025.
• A 3-year average of -$0.06 and a median of -$0.01 in 2024 frame the typical range for EPS (Basic).
• Across the five-year window, EPS (Basic) surged 97.39% in 2024 and tumbled 212134.47% in 2025, its largest moves.
• Tracing PALX's EPS (Basic) over 3 years: stood at -$0.01 in 2023, then sank by 102.91% to -$0.03 in 2024, then sank by 1632.74% to -$0.47 in 2025.
• Business Quant data shows PALX's EPS (Basic) at -$0.47 in Q3 2025, -$0.01 in Q2 2025, and -$0.01 in Q1 2025.